D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

Clinical trial NCT06622057 · RECRUITING

Trial details

NCT number: NCT06622057
Sponsor: InnoPharmax Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Biliary Tract Cancer (BTC)

Start date: 2026-06-09
Primary completion: 2028-12-31
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.